AstraZeneca’s coronavirus vaccine trial was allowed to resume in Britain, but authorities in the U.S. are still investigating the case of a patient who suffered a serious illness. The National Institutes of Health has launched an investigation into the case of a patient who suffered spinal cord damage after joining AstraZeneca’s coronavirus vaccine trial. “Everyone’s hopes are on a vaccine, …
